semaglutide and colon cancer Do GLP-1 Medications Affect Risk? New in the July 3,

For example, one of the places youll find GLP-1 naturally in the body is the brain, especially in reward-related areas

Malnutrition risk increases in elderly patients taking tirzepatide due to the combination of age related appetite decline and medication induced appetite suppression

Heres what you need to know: Protein is essential : Aim for at least 60 grams daily to preserve muscle during weight loss

Here is how they support weight loss: Reduce appetite by calming hunger signals in the brain Slow stomach emptying so you stay full longer after meals Improve insulin response to stabilize blood sugar and energy levels Encourage smaller, more controlled portions without feeling deprived Clinical research shows strong results when paired with proper nutrition: Semaglutide 2.4 mg once weekly led to an average weight loss of around 15 percent in major trials Tirzepatide, which targets both GIP and GLP-1 receptors, produced average reductions closer to 20 percent at higher doses Progress depends on consistency, dose tolerance, and adherence to a supportive lifestyle plan With the right structure and follow-up, GLP-1 therapy shifts the body toward steady, sustainable fat loss rather than rapid rebound cycles

Referral to an endocrinologist or specialist obesity clinic is particularly important if there is a suspected hormonal deficiency or if standard lifestyle measures have not achieved adequate weight management

The most common adverse events among participants treated with retatrutide (4 mg, 9 mg, 12 mg, vs